• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Rock Health: Digital Health Funding Tops $3.3B in Q3 2015

by Fred Pennic 10/05/2015 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Rock Health Q3 Digital Health Funding

Digital health funding has exceed 2014’s record breaking year reaching $3.3B representing 30% TTM growth, according to Rock Health, a full-service venture fund dedicated to digital health. In a blog post, Rock Health reported that the average deal size is the largest to date at $15.8M, despite deal flow down 9% compared to 2014. Only 8 digital health companies made up over 50% of the quarter’s total funding. 

The report produced by Teresa Wang and Rita Rajan with help from Malay Gandhi sources data from Capital IQ, SEC company websites, Crunchbase, NVCA, press releases and the Rock Health funding database. 

Key findings include:

-Series D or later funding represented 16% of deals compared to 11% through Q3 2014

– The top 6 digital health categories for funding through Q3 2015 include: 

Category Description Total Funding Largest Deal
Healthcare Consumer Engagement Consumer tools for the purchasing of healthcare products and services or heath insurance (B2B and B2C) $489M ZocDoc ($130M)
Wearable and Biosensing Wearable or accessory devices that detect specific biometrics and are designed for consumers $430M Jawbone ($300M)
Personal Health Tools and Tracking Products to assist in the tracking of personal health (e.g. physical activity, nutrition, genetics) and health reocrds $315M Helix ($100M)
Analytics and Big Data Data aggregation and/or analysis to support a wide range of healthcare use cases $233M Health Catalyst ($70M)
Telemedicine Delivery of healthcare services (synchronous or asynchronous) through non-physical means (e.g. telephone, digital imaging, video) $209M Doctor on Demand ($50M)
Payer Administration Management and administration tools for payers (e.g. fraud detection, third party payment, portal management) $164M PlanSource ($70M)

– Digital diagnostics and life sciences commercialization tools expected significant growth through Q3 2015, 195% and 110% YoY growth

– Merger and Acquisition (M&A) activity has reached a total of 146 deals YTD with EHR and clinical workflow solutions accounting for 25% of acquired deal volume  in 2015. 

It is important to note that Rock Health’s digital health funding reports only includes disclosed US deals over $2M. and companies that are sector-agnostic with a healthcare vertical are excluded. Expect these numbers to vary in comparison to StartUp Health and others as we report on digital health funding trends.

For more information, visit https://rockhealth.com/data/digital-health-research-subscription/

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Digital Health Funding, Rock Health

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |